Medicija has acquired Balsių Šeimos Medicinos Centras
October 2025 — Medicija has acquired Balsių Šeimos Medicinos Centras, a primary healthcare services provider based in Vilnius, Lithuania. The acquisition strengthens Medicija’s position in the Vilnius region and supports greater vertical integration between primary healthcare and specialist medical services. It supports the company’s strategy to build a leading full-service healthcare group with a strong presence across Lithuania’s major cities.
Medicija is a private healthcare services provider focused on fertility, specialist and primary healthcare services, with operations in Vilnius, Kaunas and Klaipėda.
Balsių Šeimos Medicinos Centras is a private family medical clinic that provides primary healthcare and specialist medical services for adults and children. With 4,000 prescribed patients, the healthcare provider is a strong regional player in Vilnius.
Our role in the transaction
Oaklins’ team in Lithuania acted as the exclusive buy-side advisor to Medicija.
Contacter l'équipe de la transaction
Natalja Titova
Oaklins Baltics
Transactions connexes
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
En apprendre plusLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
En apprendre plusSynergia and Bolster have secured acquisition financing for Life & Mobility
Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.
En apprendre plus